CSS
ALDR

Cubist Systematic Strategies’s Alder Biopharmaceuticals ALDR Stock Holding History

Cubist Systematic Strategies’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-61,803
Closed -$727K – 2652
2019
Q2 		$727K Buy
61,803
+17,062
+38% +$207K 0.01% 1227
2019
Q1 		$611K Buy
44,741
+28,144
+170% +$365K 0.02% 1058
2018
Q4 		$170K Buy
+16,597
New +$212K 0.01% 1602
2018
Q3 		– Sell
-21,639
Closed -$342K – 2195
2018
Q2 		$342K Sell
21,639
-5,975
-22% -$90.8K 0.02% 1001
2018
Q1 		$351K Buy
27,614
+3,405
+14% +$49.3K 0.02% 1044
2017
Q4 		$277K Buy
24,209
+836
+4% +$9.33K 0.01% 1307
2017
Q3 		$286K Buy
23,373
+20,089
+612% +$209K 0.02% 1206
2017
Q2 		$38K Buy
+3,284
New +$60.7K ﹤0.01% 1571
2017
Q1 		– Sell
-4,013
Closed -$83K – 1977
2016
Q4 		$83K Buy
4,013
+2,633
+191% +$68.5K 0.01% 1521
2016
Q3 		$45K Sell
1,380
-20
-1% -$609 ﹤0.01% 1579
2016
Q2 		$35K Buy
1,400
+448
+47% +$12.1K ﹤0.01% 1608
2016
Q1 		$23K Sell
952
-1,190
-56% -$27.6K ﹤0.01% 1522
2015
Q4 		$71K Sell
2,142
-4,127
-66% -$140K ﹤0.01% 1560
2015
Q3 		$205K Sell
6,269
-6,226
-50% -$265K 0.01% 1466
2015
Q2 		$662K Buy
12,495
+7,071
+130% +$257K 0.03% 796
2015
Q1 		$157K Buy
5,424
+4,918
+972% +$135K 0.01% 1596
2014
Q4 		$15K Buy
+506
New +$9.08K ﹤0.01% 1826

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cubist Systematic Strategies's ALDR Position: Q3 2019 in Review

Cubist Systematic Strategies sold out of Alder Biopharmaceuticals (ALDR) in Q3 2019, closing a stake of 61,803 shares — an estimated $727K sold.

Cubist Systematic Strategies first reported a position in ALDR in Q4 2014 and held it in 17 quarters. The position peaked at $727K in Q2 2019. 143 funds tracked by Wall St. Rank hold ALDR as of Q3 2019.

  • Cubist Systematic Strategies reported no remaining Alder Biopharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Cubist Systematic Strategies sold 61,803 Alder Biopharmaceuticals shares in Q3 2019, an estimated $727K.
  • Cubist Systematic Strategies first reported a position in Alder Biopharmaceuticals in Q4 2014 and held it in 17 quarters.
  • Cubist Systematic Strategies's Alder Biopharmaceuticals position peaked at $727K in Q2 2019.
  • 143 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2019.

Based on Cubist Systematic Strategies's 13F filing for Q3 2019, filed 14 Nov 2019.